[Biochemical changes in atherosclerosis: current concepts and experimental applications].
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism*; D001778:Blood Coagulation Disorders / Q000150:complications; D001808:Blood Vessels / Q000201:enzymology / Q000378:metabolism*; D002087:Butyrates / Q000627:therapeutic use; D002784:Cholesterol / Q000378:metabolism*; D002994:Clofibrate / Q000627:therapeutic use; D005227:Fatty Acids / Q000378:metabolism; D005342:Fibrinolysis; D006025:Glycosaminoglycans / Q000378:metabolism*; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications; D050356:Lipid Metabolism; D009539:Nicotinic Acids / Q000627:therapeutic use; D010743:Phospholipids / Q000378:metabolism; D010973:Platelet Adhesiveness; D014280:Triglycerides / Q000378:metabolism
D002087:Butyrates; D005227:Fatty Acids; D006025:Glycosaminoglycans; D006728:Hormones; D009539:Nicotinic Acids; D010743:Phospholipids; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate
Alterazioni biochimiche dell'ateroslcerosi: concetti attuali ed applicazioni sperimentali.